167. Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study. Jawaheer D, Olsen J, Lahiff M, Forsberg S, Lähteenmäki J, da Silveira IG, Rocha FA, Magalhães Laurindo IM, Henrique da Mota LM, Drosos AA, Murphy E, Sheehy C, Quirke E, Cutolo M, Rexhepi S, Dadoniene J, Verstappen SM, Sokka T. Clin Exp Rheumatol. 2010 Jul-Aug;28(4):454-61. 166. Remission makes its way to rheumatology. Sokka T, Mäkinen H. Arthritis Res Ther. 2010 Jul 14;12(4):129. 165. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. Chung CP, Oeser A, Raggi P, Sokka T, Pincus T, Solus JF, Linton MF, Fazio S, Stein CM. J Rheumatol. 2010 Aug 1;37(8):1633-8. 164. How should rheumatoid arthritis disease activity be measured today and in the future in clinical care? Sokka T. Rheum Dis Clin North Am. 2010 May;36(2):243-57. 163. Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Knevel R, Schoels M, Huizinga TW, Aletaha D, Burmester GR, Combe B, Landewé RB, Smolen JS, Sokka T, van der Heijde DM. Ann Rheum Dis. 2010 Jun;69(6):987-94. 162. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, van Vollenhoven R, Winthrop KL, Wong J, Zink A, van der Heijde D. Ann Rheum Dis. 2010 Jun;69(6):964-75. 161. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study. Sokka T, Kautiainen H, Pincus T, Verstappen SM, Aggarwal A, Alten R, Andersone D, Badsha H, Baecklund E, Belmonte M, Craig-Müller J, da Mota LM, Dimic A, Fathi NA, Ferraccioli G, Fukuda W, Géher P, Gogus F, Hajjaj-Hassouni N, Hamoud H, Haugeberg G, Henrohn D, Horslev-Petersen K, Ionescu R, Karateew D, Kuuse R, Laurindo IM, Lazovskis J, Luukkainen R, Mofti A, Murphy E, Nakajima A, Oyoo O, Pandya SC, Pohl C, Predeteanu D, Rexhepi M, Rexhepi S, Sharma B, Shono E, Sibilia J, Sierakowski S, Skopouli FN, Stropuviene S, Toloza S, Valter I, Woolf A, Yamanaka H; the QUEST-RA study group. Arthritis Res Ther. 2010 Mar 12;12(2):R42. [Epub ahead of print] 160. Treating rheumatoid arthritis to target: recommendations of an international task force. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D; T2T Expert Committee. Ann Rheum Dis. 2010 Apr;69(4):631-7. Epub 2010 Mar 9. 159. Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritis. Briggs FB, Ramsay PP, Madden E, Norris JM, Holers VM, Mikuls TR, Sokka T, Seldin MF, Gregersen PK, Criswell LA, Barcellos LF. Genes Immun. 2010 2009
158. Mäkinen H, Sokka T: Nivelreuman aktiivisuusmittareiden hyödyntäminen potilaan hoidossa. Suomen Lääkärilehti 2009:64; 2183-86. 157. Häkkinen A, Arkela-Kautiainen M, Sokka T, Hannonen P, Kautiainen H. Self-report functioning according to the ICF model in elderly patients with rheumatoid arthritis and in population controls using the multidimensional health assessment questionnaire. J Rheumatol. 2009 Feb;36(2):246-53. 156. Rho YH, Chung CP, Oeser A, Solus J, Asanuma Y, Sokka T, Pincus T, Raggi P, Gebretsadik T, Shintani A, Stein CM. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2009 Nov 15;61(11):1580-5. 155. Sokka T, Pincus T. Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov;35(4):713-22, v-vi. 154. Pincus T, Yazici Y, Sokka T. Complexities in assessment of rheumatoid arthritis: absence of a single gold standard measure. Rheum Dis Clin North Am. 2009 Nov;35(4):687-97, v. 153. Pincus T, Callahan LF, Sokka T. A Standard Protocol to Evaluate Rheumatoid Arthritis (SPERA) for efficient capture of essential data from a patient and a health professional in a uniform "scientific" format. Rheum Dis Clin North Am. 2009 Nov;35(4):843-50, xi. 152. Pincus T, Sokka T. Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov;35(4):731-4, vi-vii. 151. Yazici Y, Sokka T, Pincus T. Radiographic measures to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov;35(4):723-9, vi. 150. Sokka T. Influence of gender on the symptoms and severity of rheumatoid arthritis: do women suffer more? Int J Clin Rheumatol 2009;4(3):245-247. 149. Khan NA, Yazici Y, Calvo-Alen J, Dadoniene J, Gossec L, Hansen TM, Huisman M, Kallikorm R, Muller R, Liveborn M, Oding R, Luchikhina E, Naranjo A, Rexhepi S, Taylor P, Tlustochowich W, Tsirogianni A, Sokka T. Reevaluation of the Role of Duration of Morning Stiffness in the Assessment of Rheumatoid Arthritis Activity. J Rheumatol. 2009 Oct 15. [Epub ahead of print] 148. Liu Z, Sokka T, Maas K, Olsen N, Aune TM. Prediction of Disease Severity in Patients with Early Rheumatoid Arthritis by Gene Expression Profiling. Human Genomics and Proteomics, vol 2009, Article ID 484351, 10 pages, 2009. doi:10.4061/2009/484351 147. Pincus T, Swearingen CJ, Luta G, Sokka T. Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial. Ann Rheum Dis. 2009 Nov;68(11):1715-20. Epub 2008 Dec 15.
146. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, Carmona L, Daurès JP, de Wit M, Dijkmans BA, Englbrecht M, Gunendi Z, Heiberg T, Kirwan JR, Mola EM, Matucci-Cerinic M, Otsa K, Schett G, Sokka T, Wells GA, Aanerud GJ, Celano A, Dudkin A, Hernandez C, Koutsogianni K, Akca FN, Petre AM, Richards P, Scholte-Voshaar M, Von Krause G, Kvien TK. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis. 2009 Nov;68(11):1680-5. Epub 2008 Dec 3. 145. Sokka T, Pincus T. Rheumatoid arthritis: strategy more important than agent. Lancet 2009; 374 August 8:430-2 (Comment). 144. Palindromic Rheumatism: Longterm Outcomes of 60 Patients Diagnosed 1967-84. Koskinen E, Hannonen P, Sokka T. J Rheumatol. 2009 Jul 31. [Epub ahead of print] 143. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Sokka T, Kautiainen H, Pincus T, Toloza S, Castelar Pinheiro GD, Lazovskis J, Hetland ML, Peets T, Immonen K, Maillefert JF, Drosos AA, Alten R, Pohl C, Rojkovich B, Bresnihan B, Minnock P, Cazzato M, Bombardieri, Rexhepi S, Rexhepi M, Andersone D, Stropuviene S, Huisman M, Sierakowski S, Karateev D, Skakic V, Naranjo A, Baecklund E, Henrohn D, Gogus F, Badsha H, Taylor P, McClinton C, Yazici Y. Ann Rheum Dis. 2009 Nov;68(11):1666-72. Epub 2009 Jul 30. 142. An excellent example of an early arthritis clinic -- what is its clinical value? Sokka T, Mäkinen H. J Rheumatol. 2009 Jul;36(7):1355-6. 141. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Shintani A, Pincus T, Stein CM. Arthritis Rheum. 2009 Jun 29;60(7):1906-1914. 140. Declines in Erythrocyte Sedimentation Rates in Patients with Rheumatoid Arthritis Over the Second Half of the 20th Century. Abelson B, Sokka T, Pincus T. J Rheumatol. 2009 Jun 16. [Epub ahead of print] 139. Pincus T, Sokka T. "Keep It Simple Stupid": MDHAQ function, Pain, Global, and RAPID3 Quantitative Scores to Improve and Document Quality of Rheumatologic Care. J Rheumatol. 2009 Jun;36(6):1099-100. 138. Gregersen PK, Amos CI, Lee AT, Lu Y, Remmers EF, Kastner DL, Seldin MF, Criswell LA, Plenge RM, Holers VM, Mikuls TR, Sokka T, Moreland LW, Bridges SL Jr, Xie G, Begovich AB, Siminovitch KA. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet. 2009 Jun 7. [Epub ahead of print] 137. Erythrocyte Sedimentation Rate, C-Reactive Protein, or Rheumatoid Factor Are Normal at Presentation in 35%-45% of Patients with Rheumatoid Arthritis Seen Between 1980 and 2004: Analyses from Finland and the United States. Sokka T, Pincus T. J Rheumatol. 2009 Jul; 36(7):1387-90. 136. Long-term outcomes of rheumatoid arthritis. Sokka T. Curr Opin Rheumatol. 2009 May; 21(3):284-90. 135. Drug management of early rheumatoid arthritis - 2008. Sokka T, Mäkinen H. Best Pract Res Clin Rheumatol. 2009 Feb;23(1):93-102. Review. PMID: 19233049 [PubMed - indexed for MEDLINE].
134. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study. Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Peets T, Baranauskaite A, Géher P, Ujfalussy I, Skopouli FN, Mavrommati M, Alten R, Pohl C, Sibilia J, Stancati A, Salaffi F, Romanowski W, Zarowny-Wierzbinska D, Henrohn D, Bresnihan B, Minnock P, Knudsen LS, Jacobs JW, Calvo-Alen J, Lazovskis J, Pinheiro GD, Karateev D, Andersone D, Rexhepi S, Yazici Y, Pincus T; the QUEST-RA Group. Arthritis Res Ther. 2009 Jan 14;11(1):R7. 2008
133. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008; 26(Suppl.51):S35-S61. 132. Sokka T, Hakkinen A. Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseases. Clin Exp Rheumatol 2008; 26(Suppl.51):S14-S20. 131. Pincus T, Sokka T. Should an order to “monitor long-term vital signs”, including mortality outcomes, be as routine as an order of a laboratory test in patients with rheumatic diseases? Clin Exp Rheumatol 2008; 26(Suppl.51):S21-S24. 130. Pincus T, Sokka T. Mortality in rheumatic diseases: Introduction. Clin Exp Rheumatol 2008; 26(Suppl.51):S1-S4. 129. Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, Martin-Mola E, Matucci-Cerinic M, Michaud K, O'Dell J, Paulus H, Pincus T, Richards P, Simon L, Siegel J, Smolen JS, Sokka T, Strand V, Tugwell P, van der Heijde D, van Riel P, Vlad S, van Vollenhoven R, Ward M, Weinblatt M, Wells G, White B, Wolfe F, Zhang B, Zink A, Felson D. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum 2008 Oct 15;59(10):1371-7. 128. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis. Karonitsch T, Aletaha D, Boers M, Bombardieri S, Combe B, Dougados M, Emery P, Felson D, Gomez-Reino J, Keystone E, Kvien TK, Martin-Mola E, Matucci-Cerinic M, Richards P, van Riel P, Siegel J, Smolen JS, Sokka T, van der Heijde D, van Vollenhoven R, Ward M, Wells G, Zink A, Landewe R. Ann Rheum Dis. 2008 Oct;67(10):1365-73. 127. Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, Martin-Mola E, Matucci-Cerinic M, Michaud K, O'Dell J, Paulus H, Pincus T, Richards P, Simon L, Siegel J, Smolen JS, Sokka T, Strand V, Tugwell P, van der Heijde D, van Riel P, Vlad S, van Vollenhoven R, Ward M, Weinblatt M, Wells G, White B, Wolfe F, Zhang B, Zink A, Felson D. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis. 2008 Oct;67(10):1360-4.2008 126. Solus J, Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum. 2008 Aug 29;58(9):2662-2669.
125. Sokka T, Hetland ML, Mäkinen H, Kautiainen H, Hørslev-Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli GF, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimic A, Nedovic J, Stankovic A, Bergman M, Toloza S, Pincus T, Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis Group. Remission and Rheumatoid Arhtiritis. Data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008; 58: 2642-51. 124. Sokka T, Pincus T. Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United States. Rheumatology (Oxford). 2008 Oct;47(10):1543-7. Epub 2008 Aug 7. 123. Mäkinen H, Kautiainen H, Hannonen P, Sokka T. A new disease activity index for rheumatoid arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA). J Rheumatol. 2008 Aug;35(8):1522-7. 122. Pincus T, Bergman M, Sokka T, Roth J, Swearingen C, Yazici Y. Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data. J Rheumatol. 2008 Aug;35(8):1550-8. 121. Sokka T. Northern highlights in rheumatology. Future Rheumatol 2008;3(2):121-6. 120. Hakkinen A, Makinen H, Ylinen J, Hannonen P, Sokka T, Neva M, Kautiainen H, Kauppi M. Stability of the upper neck during isometric neck exercises in rheumatoid arthritis patients with atlantoaxial disorders. Scand J Rheumatol. 2008 Sep - Oct; 37(5): 343-7. 119. Pincus T, Sokka T. Quantitative clinical assessment in busy rheumatology settings: The value of short patient questionnaires. J Rheumatol 2008;35:1235-7 118. Chung CP, Oeser A, Solus JF, Gebretsadik T, Shintani A, Avalos I, Sokka T, Pincus T, Raggi, P, Stein CM. Inflammation-associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum. 2008 Jun 24;58(7):2105-2112. 117. Mäkinen H, Hannonen P, Sokka T. Sex: a major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis? Ann Rheum Dis 2008;67:1052-3 116. Sokka T. Radiographic Scoring in Rheumatoid Arthritis. A Short Introduction to the Methods. Bulletin of the NYU Hospital for Joint Diseases 2008;66(2):166-8 115. Pincus T, Yazici Y, Sokka T. Are excellent systematic reviews of clinical trials useful for patient care? Nat Clin Pract Rheumatol. 2008 Jun;4(6):294-5. Epub 2008 May 6. 114. Sokka T, Envalds M, Pincus T. Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod Rheumatol. 2008;18(3):228-39. 113. Naranjo A, Sokka T, Descalzo MA, Calvo-Alen J, Horslev-Petersen K, Luukkainen RK, Combe B, Burmester GR, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Tunc R, Dimic A, Bergman M, Toloza S, Pincus T. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther. 2008 Mar 6;10(2):R30.
112. Sokka T, Häkkinen A, Kautiainen H, Maillefert JF, Toloza S, Mørk Hansen T, Calvo-Alen J, Oding R, Liveborn M, Huisman M, Alten R, Pohl C, Cutolo M, Immonen K, Woolf A, Murphy E, Sheehy C, Quirke E, Celik S, Yazici Y, Tlustochowicz W, Kapolka D, Skakic V, Rojkovich B, Müller R, Stropuviene S, Andersone D, Drosos AA, Lazovskis J, Pincus T; QUEST-RA Group. Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis Rheum. 2008 Jan 15;59(1):42-50. 2007
111. Sokka T. Is the long-term outcome of rheumatoid arthritis improving? Evidence from total joint replacement surgery. Future Rheumatol 2007:2;237-9. 110. Avalos I, Chung CP, Oeser A, Gebretsadik T, Shintani A, Kurnik D, Raggi P, Sokka T, Pincus T, Stein CM. Increased Augmentation Index in Rheumatoid Arthritis and Its Relationship to Coronary Artery Atherosclerosis. J Rheumatol. 2007 Dec;34(12):2388-2394. Epub 2007 Nov 15. 109. Sokka T, Haugeberg G, Pincus T. Assessment of quality of rheumatoid arthritis care requires joint count and/or patient questionnaire data not found in a usual medical record: examples from studies of premature mortality, changes in clinical status between 1985 and 2000, and a QUEST-RA global perspective. Clin Exp Rheumatol. 2007 Nov-Dec;25(6 Suppl 47):86-97. 108. Verstappen SM, Jacobs JW, Huisman AM, van Rijthoven AW, Sokka T, Bijlsma JW. Functional Health Assessment Questionnaire (HAQ) and Psychological HAQ Are Associated with and Predicted by Different Factors in Rheumatoid Arthritis. J Rheumatol. 2007 Sep;34(9):1837-40. Epub 2007 Aug 1. 107. Pincus T, Sokka T. Can a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores be informative in patients with all rheumatic diseases? Best Pract Res Clin Rheumatol. 2007 Aug;21(4):733-53. 106. Pincus T, Sokka T. A three-page Standard Protocol to Evaluate Rheumatoid Arthritis (SPERA) for efficient capture of essential data from patients and health professionals in standard clinical care and clinical research. Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):677-85. 105. Sokka T. Quantitative assessment of rheumatoid arthritis in standard clinical care: turning clinical care into clinical science. Best Pract Res Clin Rheumatol. 2007 Aug;21(4):653-61. 104. Pincus T, Yazici Y, Sokka T. Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol. 2007 Aug;21(4):601-28. 103. Sokka T. Scandinavian registers in normal and arthritic populations. Bull NYU Hosp Jt Dis. 2007;65(2):135-8. No abstract available. 102. Makinen H, Kautiainen H, Hannonen P, Mottonen T, Korpela M, Leirisalo-Repo M, Luukkainen R, Puolakka K, Karjalainen A, Sokka T. Disease Activity Score 28 as an Instrument to Measure Disease Activity in Patients with Early Rheumatoid Arthritis. J Rheumatol. 2007 Jul 1; [Epub ahead of print]
101. Asanuma Y, Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis. 2007 Jun 12; [Epub ahead of print] 100. Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen SM, Hetland ML, Nranjo A, Baecklund E, Herborn G, Rau R, Cazzato M, Gossec L, Skakic V, Gogus F, Sierakowski S, Bresnihan B, Taylor P, McClinton C, Pincus T for the QUEST-RA Group. QUEST-RA: Quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis. 2007 Apr 5; [Epub ahead of print]. 99. Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2007 Jan 29; [Epub ahead of print]. 98. Sokka T, Makinen H, Hannonen P, Pincus T. Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Rheumatology, 2007. 97. Sokka T, Kautiainen H, Hannonen P. Stable occurrence of knee and hip total joint replacement in Central Finland between 1986 and 2003: an indication of improved long-term outcomes of rheumatoid arthritis. Ann Rheum Dis. 2007 Mar;66(3):341-4. Epub 2006 Oct 26. 96. Yazici Y, Kautiainen H, Sokka T. Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data. J Rheumatol. 2007 Feb;34(2):311-5. 95. Mäkinen, Kautiainen, Hannonen, Möttönen, Leirisalo-Repo, Laasonen, Korpela, Blåfield, Hakola, Sokka. Sustained Remission and Reduced Radiographic Progression with Combination Disease Modifying Antirheumatic Drugs in Early Rheumatoid Arthritis. J Rheumatol. 2007 Feb;34(2):316-321. Epub 2006 Dec 15. 94. Sokka T. Self-reporting instruments in rheumatoid arthritis. Nat Clin Pract Rheumatol. 2007 Feb;3(2):74-5. Epub 2007 Jan 16. 93. Luukkainen R, Sokka T, Kautiainen H, Hannonen P, Laasonen L, Leirisalo-Repo M, Korpela M, Julkunen H, Puolakka K, Blåfield H, Kauppi M, Möttönen T for the RIN-RACo group. The prognosis of 5-year radiographic erosions of the wrist according to early, late, and persistent wrist swelling or tenderness in patients with early rheumatoid arthritis. J Rheumatol 2007 ;34(1):50-3. 2006
92. Pincus T, Sokka T. Quantitative measures to assess patients with rheumatic diseases: 2006 update. Rheum Dis Clin North Am. 2006 Dec;32 Suppl 1:29-36. 91. Chung CP, Sokka T, Arbogast P, Pincus T. Work disability in rheumatoid arthritis: differences in patients with early disease in Finland and the United States. Ann Rheum Dis. 2006 Dec;65(12):1653-7. Epub 2006 Jun 1.
90. Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Utility of the Framingham Risk Score to Predict the Presence of Coronary Atherosclerosis in Patients with Rheumatoid Arthritis. Arthritis Res Ther. 2006 Dec 14;8(6):R186. 89. Makinen H, Hannonen P, Sokka T. Various definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomized clinical trials for the rate of remission. Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S022-8. 88. Sokka T, Makinen H, Puolakka K, Mottonen T, Hanonen P. Remission as the treatment goal – the FIN-RACo trial. Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S074-6. 87. Sokka T, Kautiainen H, Hannonen P, Pincus T. Changes in HAQ disability scores over 5 years in patients with rheumatoid arthritis compared to the general population. Arthritis Rheum 2006;54(10):3113-3118 86. Sokka T, Makinen H. Improving outcomes in rheumatoid: What determines decisions to change ineffective therapy? J Rheumatol 2006;33:1213-5 (Editorial). 85. Pincus T, Sokka T, Chung C, Cawkwell G. Declines of tender and swollen joint counts between 1985 and 2001 in patients with rheumatoid arthritis seen in standard care: Possible considerations for revision of inclusion criteria for clinical trials. Ann Rheum Dis. 2006 Jul;65(7):878-83. Epub 2005 Dec 8. 84. Neva MH, Häkkinen A, Mäkinen H, Kautiainen H, Hannonen P, Kauppi M, Sokka T. High prevalence of asymptomatic cervical spine subluxations in patients with rheumatoid arthritis waiting for orthopaedic surgery. Ann Rheum Dis. 2006 Jul;65(7):884-8. Epub 2005 Nov 3. 83. Pincus T, Sokka T. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients? Rheumatology 2006;45:497-9. (Editorial) 82. Pincus T, Sokka T. Evidence-based practice and practice-based evidence. Nat Clin Pract Rheumatol. 2006 Mar;2(3):114-5. 81. Häkkinen A, Kautiainen H, Hannonen P, Ylinen J, Mäkinen H, Sokka T. Muscle strength, pain, and disease activity explain individual subdimensions of the Health Assessment Questionnaire disability index, especially in women with rheumatoid arthritis. Ann Rheum Dis. 2006 Jan;65(1):30-4. Epub 2005 May 18. 2005
80. Sokka T, Hannonen P, Mottonen T. Conventional disease-modifying antirheumatic drugs in early arthritis. Rheum Dis Clin North Am. 2005 Nov;31(4):729-44. 79. Sokka T. Rheumatoid arthritis databases in Finland. Clin Exp Rheumatol 2005;23 (Suppl. 39): S201-S204 78. Sokka T, Pincus T. An early rheumatoid arthritis treatment evaluation registry (ERATER) in the United States. Clin Exp Rheumatol 2005;23 (Suppl. 39): S178-S181 77. Sokka T. Assessment of pain in rheumatic diseases. Clin Exp Rheumatol
2005;23 (Suppl. 39): S77-S84 76. Sokka T. Quantitative joint assessment in rheumatoid arthritis. Clin Exp Rheumatol 2005;23 (Suppl. 39): S58-S62 75. Pincus T, Sokka T. Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical care. Clin Exp Rheumatol 2005;23 (Suppl. 39): S1-S9 74. Chung C, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, Pincus T, Avalos I, Stein CM. Increased coronary-artery atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2005;52:3045-53. 73. Häkkinen A, Neva MH, Kautiainen H, Kauppi M, Hannonen P, Ylinen J, Mäkinen H, Jäppinen I, Sokka T. Decreased muscle strength and mobility of the neck in patients with rheumatoid arthritis and atlantoaxial disorders. Arch Phys Med Rehabil 2005 Aug;86(8):1603-8. 72. Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a multidimensional health assessment questionnaire (MDHAQ) for standard care of patients with rheumatic diseases. J Rheumatol 2005;32:1432-9. 71. Vuorela J, Kauppinen T, Sokka T. Distribution of Radiation in Synovectomy of the Knee with (166)Ho-FHMA Using Image Fusion. Cancer Biother Radiopharm. 2005 Jun;20(3):333-7. 70. Mäkinen H, Kautiainen H, Hannonen P, Sokka T. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis. 2005;64:1410-3. doi:10.1136/ard.2005.037333 69. Mäkinen H, Kautiainen H, Hannonen P, Sokka T. Frequency of remissions in early rheumatoid arthritis defined by three sets of criteria. A 5-year follow-up study. J Rheumatol 2005;32:796-800. 68. Kauppi M, Sokka T, Hannonen P. Survey non-response is associated with increased mortality in patients with rheumatoid arthritis and in community population. J Rheumatol 2005;32:807-10. 67. Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care in 2000 have significantly better clinical status than patients seen in 1985. Arthritis Rheum 2005;52:1009-19. 66. Krishnan E, Hakkinen A, Sokka T, Hannonen P. Impact of age and comorbidities on the criteria for remission and response in rheumatoid arthritis. Ann Rheum Dis. Mar 2005; 10.1136/ard.2005.037903. 65. Pincus T, Wang X, Chung C, Sokka T, Koch GG. Patient preference in a crossover clinical trial of patients with osteoarthritis of the knee or hip: Face validity of self-report questionnaire ratings. J Rheumatol 2005;32:533-9. 64. Pincus T, Sokka T. How aggressive should initial therapy for rheumatoid arthritis be? Rheumatology 44:134-5, 2005. (Letter) 2004
63. Mäkinen H, Hannonen P, Sokka T. Rheumatoid arthritis patients waiting for orthopedic surgery in Jyväskylä Central Hospital. Suomen Lääkärilehti 59:4623-6, 2004. (In Finnish)
62. Pincus T, Sokka T, Kavanaugh A. Relative versus absolute goals of therapies for RA: ACR 20 or ACR 50 responses versus target values for “near remission” of DAS or single measures. Clin Exp Rheumatol (Suppl 35) S50-S56, 2004. 61. Pincus T, Sokka T, Kavanaugh A. Quantitative documentation of risk/benefit of new therapies for rheumatoid arthritis: Patient questionnaires as an optimal measure in standard care. Clin Exp Rheumatol 22 (Suppl 35) S26-S33, 2004. 60. Pincus T, Kavanaugh A, Sokka T. Benefit/risk of therapies for rheumatoid arthritis: Underestimation of the “side effects” or risks of RA leads to underestimation of the benefit/risk of therapies. Clin Exp Rheumatol 22 (Suppl 35):S2-S11, 2004. 59. Pincus T, Sokka T. Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa? Ann Rheum Dis 63:Suppl 2:ii32ii39, 2004. 58. Pincus T, Sokka T. Quantitative measures and indices to assess rheumatoid arthritis in clinical trials and clinical care. Rheum Dis Clin North Am 30:725-51, 2004. 57. Pincus T, Sokka T. Clinical trials in rheumatic diseases: designs and limitations. Rheum Dis Clin North Am 30:701-24, 2004. 56. Sokka T, Krishnan E. National databases and rheumatology research II: the National Health and Nutrition Examination Surveys. Rheum Dis Clin North Am 30:869-79, 2004. 55. Sokka T. Rheumatoid arthritis databases. Rheum Dis Clin North Am 30:769-81. 54. Sokka T. National databases and rheumatology research I: longitudinal databases in Scandinavia. Rheum Dis Clin North Am 30:851-67, 2004. 53. Olsen NJ, Sokka T, Seehorn CL, Kraft B, Maas K, Moore JH, Aune TM. A Gene Expression Signature for Recent Onset Rheumatoid Arthritis in Peripheral Blood Mononuclear Cells. Ann Rheum Dis 63:1387-92, 2004. 52. Yazici Y, Pincus T, Kautiainen H, Sokka T. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol 31;1723-6, 2004. 51. Häkkinen A, Sokka, T, Kautiainen H, Kotaniemi A, Hannonen P. Sustained maintenance of exercise induced muscle strength gains and normal bone mineral density in patients with early rheumatoid arthritis. A five-year follow up study. Ann Rheum Dis 63;910-6, 2004. 50. Yazici Y, Sokka T, Kautiainen H, Swearingen C, Kulman I, Pincus T. Long-term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely due to laboratory abnormalities. Ann Rheum Dis 2005;64:207-11. doi:10.1136/ard.2004.023408. 49. Sokka T, Kautiainen H, Häkkinen A, Hannonen P. Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years. J Rheumatol 31;1073-82, 2004.
48. Hakkinen A, Kautiainen H, Hannonen P, Ylinen J, Arkela-Kautiainen M, Sokka T. Pain and joint mobility explain individual dimensions of the Health Assessment Questionnaire (HAQ) disability index in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:59-63. doi: 10.1136/ard.2003.019935 47. Pincus T, Koch G, Lei H, Mangal B, Sokka T, Moskowitz R, Wolfe F, Gibofsky A, Simon L, Zlotnick S, Fort J. Patient preference for Placebo, Acetaminophen or Celecoxib Efficacy Studies (PACES): Two randomized placebo-controlled cross-over clinical trials in patients with osteoarthritis of the knee or hip. Ann Rheum Dis 63;931-9, 2004. 46. Sokka T, Häkkinen A, Krishnan E, Hannonen P. Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population. Ann Rheum Dis 63;494-7, 2004. 45. Krishnan E, Sokka T, Häkkinen A, Hubert H, Hannonen P. Normative values for the Health Assessment Questionnaire Disability Index. Benchmarking disability in the general population. Arthritis Rheum 50:953-60, 2004. 44. Häkkinen A, Sokka T, Hannonen P. A home based two-year strength training period in early rheumatoid arthritis led to good long-term compliance. A five-year follow-up. Arthritis Rheum 51:56-62, 2004. 43. Pincus T, Keysor J, Sokka T, Krishnan E, Callahan LF. Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1,416 patients with rheumatoid arthritis from 15 United States private practices. J Rheumatol 31:229-34, 2004. 42. Pincus T, Sokka T. Current treatment of rheumatoid arthritis. In: Rakel RE, Bope ET, editors. Conn's Current Therapy. W.B. Saunders Company, 2004. 2003
41. Sokka T, Kautiainen H, Möttönen T, Hannonen P. Erosions develop rarely in joints without clinically detectable inflammation in patients with early rheumatoid arthritis. J Rheumatol 30:2580-4, 2003. 40. Smolen J, Sokka T, Pincus T. A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative data. Clin Exp Rheumatol 21 (Suppl 31): s209-s210, 2003. 39. Pincus T, Sokka T. Uniform databases in early arthritis: Specific measures to complement classification criteria and indices of clinical change. Clin Exp Rheumatol 21 (Suppl 31): s79-s88, 2003. 38. Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen J. Methotrexate as the ”anchor drug” for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 21 (Suppl 31): s179-s185, 2003. 37. Sokka T, Willoughby J, Yazici Y, Pincus T. Databases of patients with early rheumatoid arthritis in USA. Clin Exp Rheumatol 21 (Suppl 31): s146-s153, 2003. 36. Sokka T, Pincus T. A historical perspectivee concerning population-based and clinical studies of early arthritis and early rheumatoid arthritis. Clin Exp Rheumatol 21 (Suppl 31): s5-s14, 2003.
35. Sokka T. Early rheumatoid arthritis in Finland. Clin Exp Rheumatol 21 (Suppl 31): s133-s137, 2003. 34. Sokka T. Work disability in early rheumatoid arthritis. Clin Exp Rheumatol 21 (Suppl 31): s71-s74, 2003. 33. Pincus T, Sokka T. Quantitative measures to assess rheumatoid arthritis in clinical trials and clinical care. Best Pract Res Clin Rheumatol 17(5):753-81, 2003. 32. Neva MH, Isomäki P, Hannonen P, Kauppi M, Krisnhan E, Sokka T. Early and extensive erosiveness in peripheral joints predicts atlantoaxial subluxations in patients with rheumatoid arthritis. Arthritis Rheum 48:1808-1813, 2003. 31. Sokka T. Assessment of pain in patients with rheumatic diseases. Best Practice & Research Clinical Rheumatology 17:427-449, 2003. 30. Sokka T, Pincus T. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or American College of Rheumatology criteria for remission. J Rheumatol 30:1138-1146, 2003. 29. Krishnan E, Sokka T, Hannonen P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Res 5(3):R158-62, 2003. 28. Vuorela J, Sokka T, Pukkala E, Hannonen P. Does yttrium radiosynovectomy increase the risk of cancer in patients with rheumatoid arthritis? Ann Rheum Dis 62:251-253, 2003. 27. Häkkinen A, Sokka T, Lietsalmi AM, Kautiainen H, Hannonen P. Effects of dynamic strength training on physical function, Valpar 9 Work Sample Test and working capacity in patients with recent onset rheumatoid arthritis. Arthritis Care Res 49:71-77, 2003. 26. Sokka T, Pincus T. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor-? agents in rheumatoid arthritis. Arthritis Rheum 48:313-318, 2003. 25. Sokka T, Krishnan E, Häkkinen A, Hannonen P. Functional disability in rheumatoid arthritis patients compared with a community population in Finland. Arthritis Rheum 48:59-63, 2003. 2002
24. Sokka T, Pincus T. Contemporary DMARDs in patients with recent onset rheumatoid arthritis in a US private practice: Methotrexate as the anchor drug in 90% and new DMARDs in 30% of patients. J Rheumatol 29:2521-2524, 2002. 23. Pincus T, Ferraccioli G, Sokka T, Larsen A, Rau R, Kushner I, Wolfe F. Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology 41:1346-1356, 2002. 22. Pincus T, Sokka T. Partial control of Core data Set measures and Disease Activity Score (DAS) measures of inflammation does not prevent long-term joint damage: evidence from longitudinal observations over 5-20 years. Clin Exp Rheumatology 20 (Suppl.27): S42-S47, 2002.
21. Sokka T. Reactive Arthritis, In: Physician’s Information and Education Resource (PIER), Philadelphia, PA: American College of Physicians – American Society of Internal Medicine, 2002. 20. Pincus T, Sokka T, Stein M. Are long-term very low-doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful? Ann Intern Med 136:76-78, 2002. 2001
19. Pincus T, Sokka T. Quantitative Target Values of Predictors of Mortality in Rheumatoid Arthritis as Possible Goals for Therapeutic Interventions: an Alternative Approach to Remission or ACR20 Responses? J Rheumatol 28:1723-1734, 2001. 18. Sokka T, Pincus T. Markers for Work Disability in Rheumatoid Arthritis. J Rheumatol 28:1718-1722, 2001. 17. Pincus T, Sokka T, Wolfe F. Premature Mortality in patients with RA: Evolving Concepts. Arthritis Rheum 44:1234-1236, 2001. (Editorial) 16. Pincus T, Sokka T. How can the risk of long-term consequences of rheumatoid arthritis be reduced? Best Practice & Research Clinical Rheumatology 15:139-170, 2001. 15. Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, Luta G, Callahan LF, Wang X, Schwartz T, Abramson SB, Caldwell JR, Harrell RA, Kremer JM, Lautzenheiser RL, Markenson JA, Schnizer TJ, Weaver A, Cummins P, Wilson A, Morant S, Fort J. A randomized double blind crossover clinical trial to compare diclofenac + misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 44:1587-1598, 2001. 14. Häkkinen A, Sokka T, Kotaniemi A, Hannonen P. A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity and bone mineral density in early rheumatoid arthritis. Arthritis Rheum 44:515-522, 2001. 2000
13. Sokka T, Kankainen A, Hannonen P. Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores. Arthritis Rheum 43:386-389, 2000. 12. Sokka T, Hannonen P. Healing of erosions in rheumatoid arthritis. Ann Rheum Dis 59:647-649, 2000. 11. Sokka T, Möttönen T, Hannonen P. Disease-modifying anti-rheumatic drug use according to the “sawtooth” treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature. Rheumatology 39:34-42, 2000. 1999
10. Sokka T. Extensive use of antirheumatic drugs improves long-term outcomes in patients with rheumatoid arthritis. Kuopio University Publications D. URL-address: www.uku.fi/tutkimus/vaitokset/1999. Doctoral Thesis.
9. Sokka T, Möttönen T, Hannonen P. Mortality in early “sawtooth” treated rheumatoid arthritis patients during the first 8-14 years. Scand J Rheumatol 28:282-287, 1999. 8. Sokka T, Kaarela K, Möttönen T, Hannonen P. Conventional monotherapy compared to a “sawtooth” treatment strategy in the radiographic progression of rheumatoid arthritis over the first eight years. Clinic Exp Rheumatol 17:527-532, 1999. 7. Sokka T, Hannonen P. Utility of disease modifying antirheumatic drugs in “sawtooth” strategy. A prospective study of early rheumatoid arthritis patients up to 15 years. Ann Rheum Dis 58:618-622, 1999. 6. Sokka T, Kautiainen H, Möttönen T, Hannonen P. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 26:1681-1685, 1999. 5. Häkkinen A, Sokka T, Kotaniemi A, Kautiainen H, Jäppinen I, Laitinen L, Hannonen P. Dynamic strength training in patients with early rheumatoid arthritis increases muscle strength but not bone mineral density. J Rheumatol 26:1257-1263, 1999. 4. Häkkinen A, Sokka T, Kotaniemi A, Paananen ML, Mälkiä E, Kautiainen H, Hannonen P. Muscle strength characteristics and central bone mineral density in women with recent onset rheumatoid arthritis compared with healthy controls. Scand J Rheumatol 28:145-151, 1999. 1998
3. Voutilainen M, Sokka T, Juhola M, Färkkila M, Hannonen P. Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer. Scand J Gastroenterol 33:811-816, 1998. 2. Häkkinen A, Mälkiä E, Sokka T, Hannonen P. A physically demanding occupation predicts premature retirement among patients with erosive arthritis. Physiotherapy Theory and Practice 14;13-22, 1998. 1997
1. Sokka TM, Kautiainen HJ, Hannonen PJ. A retrospective study of treating RA patients with various combinations of slow-acting antirheumatic drugs in a county hospital. Scand J Rheumatol 26:440-443, 1997.
Diarionline - Novo método tem maior taxa de sucesso contra o cigarrohttp://www.diarionline.com.br/index.php?s=noticia&id=30723Expediente | Fale Conosco | Anunciar no site | Leia Online | Assine Inicial Diario Minuto Artigos Galerias Agropecuária Brasil Carnaval Carnaval 2011 Cidadania Cidade Clima Cultura Economia Educação Entretenimen Saúde Novo método tem maior
Section 1: British Pantomimes Part 5: Mid-Sized Pantomimes (with a chorus) (Page 1) (Chorus increases flexibility of numbers.)These shows are a mixture of scripts written for schools and children’s groups, and short pieces written for performance by adults or mixes of adults and children. The quoted run-times are a guideline only; so much depends on an individual production. Aladd